Michael Altorfer, Ph.D.
Michael Altorfer, Ph.D., Head Corporate Development and deputy CEO, started his career as a scientist in pharmaceutical research at Sandoz, Ciba-Geigy (Summit NJ, USA), and Roche before moving to finance. From 1996-2001 he has been holding program management and line management roles at the investment bank UBS Warburg. Dr. Michael Altorfer studied Natural Sciences at the Swiss Federal Institute of Technology (ETH) in Zurich, with the main focus on Chemistry, Toxicology, and Immunology. He obtained his Ph.D. in Chemistry in 1996 under the supervision of Prof. Dr. H.-J. Hansen (University of Zurich) and Prof. Dr. K. Müller (Roche) and an MBA degree from the University of Rochester, NY, USA in 2000.
